4.7 Review

Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment

期刊

出版社

MDPI
DOI: 10.3390/ijms22042146

关键词

oxytocin; schizophrenia; social cognition; psychopathology

资金

  1. Wan-Fang Hospital, Taipei Medical University [110-eva-13]
  2. Ministry of Education
  3. Ministry of Science and Technology, Taiwan [MOST108-2314-B-038-077, MOST109-2314-B-038-084, MOST1092314-B-038-023-MY2]
  4. China Medical University [CMU109-MOST-03]

向作者/读者索取更多资源

Schizophrenia is characterized by abnormal behavior, and dysregulation of oxytocin may play a role in its expression. Studies have shown potential clinical benefits of oxytocin in improving the psychopathology of patients with schizophrenia. Oxytocin has the potential to be a therapeutic agent for schizophrenia and may have implications for future treatment.
Schizophrenia is a form of mental disorder that is behaviorally characterized by abnormal behavior, such as social function deficits or other behaviors that are disconnected from reality. Dysregulation of oxytocin may play a role in regulating the expression of schizophrenia. Given oxytocin's role in social cognition and behavior, a variety of studies have examined the potential clinical benefits of oxytocin in improving the psychopathology of patients with schizophrenia. In this review, we highlight the evidence for the role of endogenous oxytocin in schizophrenia, from animal models to human studies. We further discuss the potential of oxytocin as a therapeutic agent for schizophrenia and its implication in future treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据